0001209191-19-023521.txt : 20190403
0001209191-19-023521.hdr.sgml : 20190403
20190403194212
ACCESSION NUMBER: 0001209191-19-023521
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190403
DATE AS OF CHANGE: 20190403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Currie Mark G
CENTRAL INDEX KEY: 0001478244
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38787
FILM NUMBER: 19730820
MAIL ADDRESS:
STREET 1: C/O CYCLERION THERAPEUTICS, INC.
STREET 2: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001755237
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831895370
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-01
0
0001755237
Cyclerion Therapeutics, Inc.
CYCN
0001478244
Currie Mark G
C/O CYCLERION THERAPEUTICS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
President
Common Stock
2019-04-01
4
A
0
51648
0.00
A
51648
D
Common Stock
2019-04-02
4
P
0
270107
14.81
A
321755
D
Employee Stock Option (Right to Buy)
12.39
2019-04-01
4
A
0
888
0.00
A
2020-02-02
Common Stock
888
888
D
Employee Stock Option (Right to Buy)
12.23
2019-04-01
4
A
0
37286
0.00
A
2021-02-01
Common Stock
37286
37286
D
Employee Stock Option (Right to Buy)
16.21
2019-04-01
4
A
0
17491
0.00
A
2022-02-01
Common Stock
17491
17491
D
Employee Stock Option (Right to Buy)
14.40
2019-04-01
4
A
0
27773
0.00
A
2023-02-01
Common Stock
27773
27773
D
Employee Stock Option (Right to Buy)
15.54
2019-04-01
4
A
0
9930
0.00
A
2024-03-03
Common Stock
9930
9930
D
Employee Stock Option (Right to Buy)
17.20
2019-04-01
4
A
0
13125
0.00
A
2025-03-16
Common Stock
13125
13125
D
Employee Stock Option (Right to Buy)
17.20
2019-04-01
4
A
0
2500
0.00
A
2025-03-16
Common Stock
2500
2500
D
Employee Stock Option (Right to Buy)
11.28
2019-04-01
4
A
0
50801
0.00
A
2026-03-01
Common Stock
50801
50801
D
Employee Stock Option (Right to Buy)
18.46
2019-04-01
4
A
0
113430
0.00
A
2027-02-27
Common Stock
113430
113430
D
Employee Stock Option (Right to Buy)
16.02
2019-04-01
4
A
0
141007
0.00
A
2028-02-21
Common Stock
141007
141007
D
Employee Stock Option (Right to Buy)
14.20
2019-04-01
4
A
0
514786
0.00
A
2029-01-29
Common Stock
514786
514786
D
In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received Cyclerion shares representing an equitable adjustment of Ironwood shares held by the reporting person prior to the Separation.
Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation.
This option, granted as an annual performance award, is presently exercisable in full.
This option to purchase 25,212 shares vests in equal installments upon achievement of certain regulatory and commercial milestones. The option has vested as to 2,500 shares as of the date hereof.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2016.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2017.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2018.
The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2019.
/s/ Larry Miller, Attorney-in-Fact
2019-04-03